These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6195613)
21. Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs. Platou ES; Refsum H J Cardiovasc Pharmacol; 1982; 4(5):839-46. PubMed ID: 6182417 [TBL] [Abstract][Full Text] [Related]
22. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. Podrid PJ; Lown B Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665 [TBL] [Abstract][Full Text] [Related]
23. Use of amiodarone in the therapy of primary ventricular arrhythmias in children. Pickoff AS; Singh S; Flinn CJ; Wolff GS; Gelband H Dev Pharmacol Ther; 1983; 6(2):73-82. PubMed ID: 6861598 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Strasberg B; Arditti A; Sclarovsky S; Lewin RF; Buimovici B; Agmon J Int J Cardiol; 1985 Jan; 7(1):47-58. PubMed ID: 4055134 [TBL] [Abstract][Full Text] [Related]
29. [Clinical study of amiodarone in cardiac rhythmic disorders]. Van Schepdael J; Solvay H Presse Med (1893); 1970 Oct; 78(42):1849-50. PubMed ID: 4096989 [No Abstract] [Full Text] [Related]
30. Clinical experience with verapamil. Vohra J; Hunt D; Sloman G Med J Aust; 1975 Sep; 2(11):417-21. PubMed ID: 1186549 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Nademanee K; Hendrickson J; Kannan R; Singh BN Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035 [No Abstract] [Full Text] [Related]
32. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia. Celiker A; Koçak G; Lenk MK; Alehan D; Ozme S Turk J Pediatr; 1997; 39(2):219-25. PubMed ID: 9223920 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of amiodarone in resistant arrhythmias. Hollman A; Holt PM J R Soc Med; 1980 Dec; 73(12):842-4. PubMed ID: 7452643 [TBL] [Abstract][Full Text] [Related]
34. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias]. Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187 [TBL] [Abstract][Full Text] [Related]
35. Amiodarone for ventricular arrhythmias. N Engl J Med; 1981 Dec; 305(26):1587-9. PubMed ID: 7312002 [No Abstract] [Full Text] [Related]
36. Amiodarone: value of programmed electrical stimulation and Holter monitoring. Fisher JD; Kim SG; Waspe LE; Johnston DR Pacing Clin Electrophysiol; 1986 May; 9(3):422-35. PubMed ID: 2423985 [TBL] [Abstract][Full Text] [Related]
37. Clinical experience with propafenone for cardiac arrhythmias in the young. Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342 [TBL] [Abstract][Full Text] [Related]
38. Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. Mostow ND; Vrobel TR; Noon D; Rakita L Am Heart J; 1990 Dec; 120(6 Pt 1):1356-63. PubMed ID: 2248182 [TBL] [Abstract][Full Text] [Related]